RYTM logo

Rhythm Pharmaceuticals, Inc. (RYTM) Cash From Operations

Annual CFO:

-$113.88M+$22.28M(+16.36%)
December 31, 2024

Summary

  • As of today, RYTM annual cash from operations is -$113.88 million, with the most recent change of +$22.28 million (+16.36%) on December 31, 2024.
  • During the last 3 years, RYTM annual cash from operations has risen by +$32.12 million (+22.00%).
  • RYTM annual cash from operations is now -1586.60% below its all-time high of -$6.75 million, reached on December 31, 2015.

Performance

RYTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMcash flow metrics

Quarterly CFO:

-$23.31M+$17.04M(+42.22%)
June 30, 2025

Summary

  • As of today, RYTM quarterly cash from operations is -$23.31 million, with the most recent change of +$17.04 million (+42.22%) on June 30, 2025.
  • Over the past year, RYTM quarterly cash from operations has increased by +$5.76 million (+19.82%).
  • RYTM quarterly cash from operations is now -578.49% below its all-time high of -$3.44 million, reached on December 1, 2015.

Performance

RYTM Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMcash flow metrics

TTM CFO:

-$107.72M+$5.76M(+5.08%)
June 30, 2025

Summary

  • As of today, RYTM TTM cash from operations is -$107.72 million, with the most recent change of +$5.76 million (+5.08%) on June 30, 2025.
  • Over the past year, RYTM TTM cash from operations has increased by +$20.73 million (+16.14%).
  • RYTM TTM cash from operations is now -3035.16% below its all-time high of -$3.44 million, reached on December 1, 2015.

Performance

RYTM TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

RYTM Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+16.4%+19.8%+16.1%
3Y3 Years+22.0%+39.9%+37.8%
5Y5 Years+7.2%+21.6%+13.9%

RYTM Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+34.3%-23.7%+50.4%at high+40.1%
5Y5-Yearat high+34.3%-23.7%+56.5%at high+40.1%
All-TimeAll-Time-1586.6%+34.3%-578.5%+56.5%-3035.2%+40.1%

RYTM Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$23.31M(+42.2%)
-$107.72M(+5.1%)
Mar 2025
-
-$40.35M(-114.1%)
-$113.49M(+0.3%)
Dec 2024
-$113.88M(+16.4%)
-$18.84M(+25.3%)
-$113.88M(+8.5%)
Sep 2024
-
-$25.21M(+13.3%)
-$124.42M(+3.1%)
Jun 2024
-
-$29.08M(+28.6%)
-$128.45M(+8.6%)
Mar 2024
-
-$40.74M(-38.7%)
-$140.47M(-3.2%)
Dec 2023
-$136.16M(+21.5%)
-$29.38M(-0.5%)
-$136.16M(+3.3%)
Sep 2023
-
-$29.25M(+28.8%)
-$140.77M(+11.2%)
Jun 2023
-
-$41.09M(-12.8%)
-$158.51M(-1.5%)
Mar 2023
-
-$36.43M(-7.2%)
-$156.23M(+9.9%)
Dec 2022
-$173.43M(-18.8%)
-$34.00M(+27.6%)
-$173.43M(+3.6%)
Sep 2022
-
-$46.99M(-21.1%)
-$179.90M(-3.9%)
Jun 2022
-
-$38.81M(+27.6%)
-$173.07M(-4.2%)
Mar 2022
-
-$53.63M(-32.5%)
-$166.10M(-13.8%)
Dec 2021
-$146.00M(-19.7%)
-$40.47M(-0.8%)
-$146.00M(-8.4%)
Sep 2021
-
-$40.16M(-26.1%)
-$134.65M(-10.8%)
Jun 2021
-
-$31.84M(+5.0%)
-$121.52M(-1.8%)
Mar 2021
-
-$33.53M(-15.1%)
-$119.41M(+2.1%)
Dec 2020
-$121.98M
-$29.12M(-7.7%)
-$121.98M(+2.5%)
Sep 2020
-
-$27.03M(+9.1%)
-$125.08M(+5.0%)
Jun 2020
-
-$29.73M(+17.6%)
-$131.65M(-3.3%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$36.10M(-12.0%)
-$127.47M(-3.8%)
Dec 2019
-$122.75M(-97.8%)
-$32.22M(+4.1%)
-$122.75M(-10.1%)
Sep 2019
-
-$33.60M(-31.5%)
-$111.51M(-17.6%)
Jun 2019
-
-$25.55M(+18.6%)
-$94.85M(-16.0%)
Mar 2019
-
-$31.38M(-49.5%)
-$81.78M(-31.8%)
Dec 2018
-$62.06M(-110.6%)
-$20.98M(-23.9%)
-$62.06M(-26.8%)
Sep 2018
-
-$16.94M(-35.8%)
-$48.96M(-21.1%)
Jun 2018
-
-$12.48M(-7.1%)
-$40.43M(-18.6%)
Mar 2018
-
-$11.65M(-47.8%)
-$34.09M(-15.7%)
Dec 2017
-$29.46M(-26.9%)
-$7.88M(+6.3%)
-$29.46M(-36.5%)
Sep 2017
-
-$8.42M(-37.0%)
-$21.57M(-64.0%)
Jun 2017
-
-$6.14M(+12.5%)
-$13.16M(+0.5%)
Mar 2017
-
-$7.02M(-13.0%)
-$13.23M(+17.5%)
Dec 2016
-$23.22M(-243.9%)
-
-
Jun 2016
-
-$6.21M(+2.8%)
-$16.03M(-63.2%)
Mar 2016
-
-$6.39M(-85.9%)
-$9.82M(-185.9%)
Dec 2015
-$6.75M(+10.1%)
-
-
Dec 2015
-
-$3.44M
-$3.44M
Dec 2014
-$7.51M(+60.8%)
-
-
Dec 2013
-$19.16M(-7.4%)
-
-
Dec 2012
-$17.83M
-
-

FAQ

  • What is Rhythm Pharmaceuticals, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. annual cash from operations year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

What is Rhythm Pharmaceuticals, Inc. annual cash from operations?

The current annual cash from operations of RYTM is -$113.88M

What is the all-time high annual cash from operations for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high annual cash from operations is -$6.75M

What is Rhythm Pharmaceuticals, Inc. annual cash from operations year-on-year change?

Over the past year, RYTM annual cash from operations has changed by +$22.28M (+16.36%)

What is Rhythm Pharmaceuticals, Inc. quarterly cash from operations?

The current quarterly cash from operations of RYTM is -$23.31M

What is the all-time high quarterly cash from operations for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high quarterly cash from operations is -$3.44M

What is Rhythm Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?

Over the past year, RYTM quarterly cash from operations has changed by +$5.76M (+19.82%)

What is Rhythm Pharmaceuticals, Inc. TTM cash from operations?

The current TTM cash from operations of RYTM is -$107.72M

What is the all-time high TTM cash from operations for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high TTM cash from operations is -$3.44M

What is Rhythm Pharmaceuticals, Inc. TTM cash from operations year-on-year change?

Over the past year, RYTM TTM cash from operations has changed by +$20.73M (+16.14%)
On this page